161 related articles for article (PubMed ID: 32454863)
1. The Role of Xuefu Zhuyu Decoction in Prevention of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention.
Zhao J; Liu H; Xu B; Peng J; Xing Y; Tang W; Peng F
Evid Based Complement Alternat Med; 2020; 2020():5419016. PubMed ID: 32454863
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and mechanism of Xuefu Zhuyu Decoction on model rats of coronary heart disease with heart blood stasis syndrome based on metabolomics].
Li J; Guo ZH; Liu JH; Zhong SJ; Kuang HF; Yang Y; Liu Y; Zhang QY
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(20):5623-5631. PubMed ID: 38114155
[TBL] [Abstract][Full Text] [Related]
3. [Effects of Xuefu Zhuyu decoction on serum asymmetric dimethylarginine in atherosclerosis rabbits].
Li Y; Zhao A; Zeng H; Lin G; Jiang H
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1530-4. PubMed ID: 19777840
[TBL] [Abstract][Full Text] [Related]
4. [Effect of probucol on preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention].
Suo XQ; Yang SC; Ma ZH; Sun TT; Zhang WY; Cong HL; Lin WH; Lu CZ; Tian FS; Fu NK
Zhonghua Yi Xue Za Zhi; 2017 Nov; 97(41):3234-3238. PubMed ID: 29141361
[No Abstract] [Full Text] [Related]
5. [Effects of Chinese herbal medicine Xuefu Zhuyu Decoction on angiotensin II-induced proliferation and extracellular matrix synthesis of rat cardiac fibroblasts].
Shen Y; Wei H; Jin CL
Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):313-9. PubMed ID: 21419085
[TBL] [Abstract][Full Text] [Related]
6. The mechanisms underlying the actions of Xuefu Zhuyu decoction pretreatment against neurological deficits after ischemic stroke in mice: The mediation of glymphatic function by aquaporin-4 and its anchoring proteins.
Yi T; Gao P; Hou M; Lv H; Huang M; Gao S; He J; Yang D; Chen W; Zhu T; Yu C; Liu F; Yin H; Jin S
Front Pharmacol; 2022; 13():1053253. PubMed ID: 36582539
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Gualou Xiebai Banxia decoction combined with Xuefu Zhuyu decoction on myocardial apoptosis and relevant protein expressions in miniature swine phlegm and blood stasis type coronary heart disease model].
Yan AG; Liu JX; Li XZ; Dong XX; Li HK
Zhongguo Zhong Yao Za Zhi; 2015 Jun; 40(11):2174-9. PubMed ID: 26552176
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Xuefu Zhuyu Decoction in treatment of myocardial infarction based on network pharmacology and molecular docking].
Lin JG; Yao KW; Wang QQ; Hua X
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):885-893. PubMed ID: 33645093
[TBL] [Abstract][Full Text] [Related]
11.
Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of anisodamine on prevention of contrast induced nephropathy in patients with acute coronary syndrome.
Wang YB; Fu XH; Gu XS; Wang XC; Zhao YJ; Hao GZ; Jiang YF; Fan WZ; Wu WL; Li SQ; Xue L
Chin Med J (Engl); 2012 Mar; 125(6):1063-7. PubMed ID: 22613532
[TBL] [Abstract][Full Text] [Related]
13. The effect of Xuefu Zhuyu decoction on clopidogrel resistance and its association with the P2Y12 Gene polymorphisms and promoter DNA methylation.
Yu Q; Su J; Zhu K; Yang S; Zhu H; Yu J
Pak J Pharm Sci; 2019 Nov; 32(6):2565-2572. PubMed ID: 31969287
[TBL] [Abstract][Full Text] [Related]
14. The prophylactic effect of alprostadil on contrast-induced nephropathy in renal insufficiency patients after percutaneous coronary intervention.
Liu D; Gao F; Li L; Jian X; Xiao B
Am J Transl Res; 2021; 13(4):3766-3772. PubMed ID: 34017563
[TBL] [Abstract][Full Text] [Related]
15. Effects of Xuefu Zhuyu Granules on Patients with Stable Coronary Heart Disease: A Double-Blind, Randomized, and Placebo-Controlled Study.
Li Y; Tao T; Song D; He T; Liu X
Oxid Med Cell Longev; 2021; 2021():8877296. PubMed ID: 34326921
[TBL] [Abstract][Full Text] [Related]
16.
Zhu L; Tang T; Fan R; Luo JK; Cui HJ; Zhang CH; Peng WJ; Sun P; Xiong XG; Wang Y
Neural Regen Res; 2018 Aug; 13(8):1417-1424. PubMed ID: 30106054
[TBL] [Abstract][Full Text] [Related]
17. Combined use of hydration and alprostadil for preventing contrast-induced nephropathy following percutaneous coronary intervention in elderly patients.
Xu RH; Ma GZ; Cai ZX; Chen P; Zhu ZD; Wang WL
Exp Ther Med; 2013 Oct; 6(4):863-867. PubMed ID: 24137279
[TBL] [Abstract][Full Text] [Related]
18. Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome.
Zhou F; Song W; Wang Z; Yin L; Yang S; Yang F; Song Z; Song Y; Zhang H; Qiao F; Zhang Z
Medicine (Baltimore); 2018 Jan; 97(2):e9579. PubMed ID: 29480853
[TBL] [Abstract][Full Text] [Related]
19. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
[TBL] [Abstract][Full Text] [Related]
20. Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis.
Yuan J; Yan F; Li W; Yuan G
Front Pharmacol; 2022; 13():1069704. PubMed ID: 36532728
[No Abstract] [Full Text] [Related]
[Next] [New Search]
